Talking Psychedelics: Spencer Hawkswell of TheraPsil

Welcome to “Talking Psychedelics”, where Frshminds takes you on a deep dive with the driving forces shaping the psychedelics industry. Today we have the pleasure of sitting down with Spencer Hawkswell of TheraPsil. TheraPsil is a patient advocacy group working to get safe, legal, equitable or timely access to medical psilocybin and psilocybin therapy for all Canadians. They have been active in getting Section 56 exceptions for patients as well Special Access Program requests for psilocybin.

We will have more coverage of TheraPsil in the coming weeks, but if you care about getting equitable access to psilocybin, put your money where your mouth is and donate to the cause. Changing government policy is neither cheap nor easy, so you can do your part and contribute a few dollars.

Learn more about the link between psychedelics and mental well-being in our Ultimate Psychedelics and Mental Wellness Guide!

Recent Episodes of Talking Psychedelics

About the Author

Josh has diverse background with a combination of formal training in both healthcare and business administration. Currently the CTO of Frshminds, he has a life long interest in alternative approaches to healthcare as well as technology development. Prior to working on Frshminds, he was the CTO of Lift & Co, a cannabis information site and ran Extreme Innovations, the in house software development services company of Extreme Venture Partners, one of the most successful early stage venture investors in Canada. Since becoming interested in psychedelics, Josh has explored microdosing, mushroom cultivation and was responsible for building out Frshminds' mushroom species guide.

Talking Psychedelics: Spencer Hawkswell of TheraPsil

Recent Episodes of Talking Psychedelics

About the Author

Earn points.
Unlock rewards.

Comments